Sigma Lithium Corporation SGML
As ofNov 20, 2026, 2:45 PM EST
- YTD
- -71.42%
- 1 year
- -59.89%
Fundamental scorecard
5 of 25 checks passed on SGML’s reported financials
5of 25 checks passed
- Value 3 of 5
- Growth 0 of 5
- Profitability 1 of 5
- Financial health 1 of 5
- Dividend No data
Statements to Sep 30, 2026.
Value 3 of 5
- Failed:P/E below its own 5-year median No profit over the last 12 months, so no P/E.
- Failed:P/E under 20 No profit over the last 12 months, so no P/E.
- Passed:Price to sales below its own 5-year median Price to sales 4.7 against a 5-year median of 18.3.
- Passed:Price to book below its own 5-year median Price to book 10.5 against a 5-year median of 21.1.
- Passed:Free cash flow yield above 4% Free cash flow of 49.2M is 8.1% of the market value.
Growth 0 of 5
- Failed:Revenue grew over the last year Revenue of 127M is -9.2% on the 12 months before.
- No data:Revenue grew more than 5% a year over five years Not enough data to decide.
- Failed:Earnings per share grew over the last year EPS -0.37 against -0.30 in the 12 months before.
- Failed:Earnings per share grew more than 5% a year over five years EPS -0.02 in FY 2020, -0.45 in FY 2025.
- No data:Analysts expect higher earnings per share over the next year No analyst estimate.
Profitability 1 of 5
- Failed:Profitable over the last year Net income of -41.9M over the last 12 months.
- Failed:Profitable in each of the last five fiscal years A profit in 0 of the last 5 fiscal years.
- Failed:Return on equity above 15% Return on equity of -59.2%.
- Passed:Net margin above its 5-year average Net margin of -32.8% against a 5-year average of -33.6%.
- Failed:Free cash flow is at least 80% of net income No profit over the last 12 months to compare with.
Financial health 1 of 5
- Failed:Short-term assets cover short-term liabilities Short-term assets of 55.1M against short-term liabilities of 274M.
- Failed:Short-term assets cover long-term liabilities Short-term assets of 55.1M against long-term liabilities of 124M.
- Failed:Net debt under 40% of equity Net debt of 257M is 445.1% of equity.
- Passed:Operating cash flow covers at least 20% of debt Operating cash flow of 60.3M is 21.7% of debt.
- Failed:Operating profit covers interest at least 3 times Operating profit is 0.2 times the interest expense.
Dividend No data
- No data:Pays a dividend Not enough data to decide.
- No data:Yield above 1.5% Not enough data to decide.
- No data:Pays out under 75% of profit Not enough data to decide.
- No data:Covered by free cash flow Not enough data to decide.
- No data:Not cut in the last five fiscal years Not enough data to decide.
Mechanical checks on reported financials against fixed thresholds. They describe the numbers; they are not a recommendation to buy or sell. Amounts are in the company’s reporting currency.
Included in Essentials and up
Sign in to see Fair value
Discounted cash flow estimates against the price, and the P/E against its industry and sector.
Included in Essentials and up
Sign in to see Head count and owner earnings
Employees by annual report and the cash the business earns for its owners.
Included in Essentials and up
Sign in to see P/E against peers
The price to earnings ratio beside the closest competitors and their median.
Financial position
What SGML owns and owes, as of Sep 30, 2026
Short term and long term
Balance sheet · 456M of assets
Debt, equity and cash by year
Now: 257M of debt after cash
Fiscal years, then the newest quarter. Cash includes short-term investments.
From the company’s SEC filings, in its reporting currency.
Included in Essentials and up
Sign in to see Cash flow and returns
How profit turns into free cash flow, and the returns on equity, assets and capital.
Financial health
Altman Z-Score
-0.14 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C-1 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
Profitability
Growth (YoY)
Financial Health
Dividends
Annual · latest fiscal year ends 2025-12-31
